Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5S ribosomal RNA pseudogenes, such as RNA5SP192, are non-functional DNA elements resembling the 5S rRNA gene but do not encode a functional RNA product[2][8]. 5S rRNA is a small, highly conserved RNA component of the large ribosomal subunit, essential for protein synthesis in all domains of life except mitochondrial ribosomes of animals and fungi[1][3][5][7]. However, the "pseudogene" designation means that RNA5SP192 lacks the ability to produce a functional 5S rRNA molecule due to disruptions or mutations in its sequence[2][8]. Pseudogenes can arise from gene duplication (nonprocessed), retrotransposition (processed), or other genetic events, and generally do not have a known physiological or pathological function. Some pseudogenes may have regulatory or structural effects, but there is no specific evidence for any function or therapeutic role of RNA5SP192[4][2][8]. There are no known interacting drugs, disease associations, biomarker roles, or safety concerns related to RNA5SP192, and it is not considered a molecular target in drug development or disease research. The inclusion of “pseudogene” and the high locus number (192) indicate it is one of many similar, non-functional copies of 5S rRNA found in the genome[2][8]. If you seek a genuine therapeutic target, the canonical entry would be "5S ribosomal RNA" (not this pseudogene)[1][3][5][7]. In summary, RNA5SP192 is not a valid molecular target due to its pseudogene status.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5S ribosomal RNA pseudogene 192 (RNA5SP192).